Fortescue Ltd
FMG
Woodside Energy Group Ltd
WDS
Origin Energy Ltd
ORG
Telstra Group Ltd
TLS
BHP Group Ltd
BHP
AU Stock MarketDetailed Quotes
ATX Amplia Therapeutics Ltd
- 0.083
- 0.0000.00%
20min DelayNot Open Dec 20 16:00 AET
31.97MMarket Cap-3.77P/E (Static)
0.000High0.000Low0Volume0.000Open0.083Pre Close0.00Turnover0.18052wk High0.00%Turnover Ratio385.13MShares0.05552wk Low-0.027EPS TTM18.67MFloat Cap167.493Historical HighLossP/E (Static)224.96MShs Float0.041Historical Low-0.022EPS LYR0.00%Amplitude--Dividend TTM2.52P/B1Lot Size--Div YieldTTM
About Amplia Therapeutics Ltd Company
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.
Company Profile
SymbolATX
Company NameAmplia Therapeutics Ltd
Founded2013
MarketASX
Fiscal Year Ends03-31
Address350 Queen Street Level 17
CityMelbourne
CountryAustralia
Zip Code3000
Phone+61 280033650
Websitehttps://www.ampliatx.com
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED
Yarra Falls, 452 Johnston Street, ABBOTSFORD, VIC, AUSTRALIA, 3067
03 9415 4000
Company Executives
- Name
- Position
- Salary
- Christopher John Burns
- Non Executive Director,Chief Executive Officer,Managing Director
- --
- Warwick Bonner Tong
- Non-Executive Director,Non-Executive Chairman
- --
- Robert Peach
- Non-Executive Director
- --
- Jane Catherine Bell
- Non-Executive Director
- --